Helen J. Hathaway

In vivo effects of a GPR30 antagonist

Megan K. Dennis, Ritwik Burai, Chinnasamy Ramesh et al. · Nature Chemical Biology · 2009 · 514 citations · Full text

Functional Selectivity, Medicine, Pharmacological Agent +5

Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity

Megan K. Dennis, Angela S. Field, Ritwik Burai et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2011 · 303 citations · Full text

Endocrine Mechanism, Gper/gpr30 Antagonist, Medicine +7

GPER Deficiency in Male Mice Results in Insulin Resistance, Dyslipidemia, and a Proinflammatory State

Geetanjali Sharma, Chelin Hu, Jonathan L. Brigman et al. · Endocrinology · 2013 · 226 citations · Full text

Gper Deficiency, Male Mice Results, Metabolic Disorder +16

GPR30 predicts poor survival for ovarian cancer

Harriet O. Smith, Hugo Arias‐Pulido, Dennis Yi‐Shin Kuo et al. · Gynecologic Oncology · 2009 · 203 citations · Full text

Medicine, Cancer Management, Gynecology +4

G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth

Whitney K. Petrie, Megan K. Dennis, Chelin Hu et al. · Obstetrics and Gynecology International · 2013 · 162 citations · Full text

Tumor Biology, Medicine, Hormonal Receptor +12